Technical Analysis for AVCO - Avalon GloboCare Corp.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical AVCO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 2.00% | |
| New 52 Week Low | Weakness | 2.00% | |
| Oversold Stochastic | Weakness | 2.00% | |
| New 52 Week Low | Weakness | -2.86% | |
| Oversold Stochastic | Weakness | -2.86% | |
| Stochastic Buy Signal | Bullish | -2.86% | |
| Narrow Range Bar | Range Contraction | -2.86% | |
| Oversold Stochastic | Weakness | -2.86% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Possible Pocket Pivot | about 14 hours ago |
| 2x Volume Pace | about 18 hours ago |
| Reversed from Up | about 19 hours ago |
| Rose Above Previous Day's High | about 20 hours ago |
| 10 DMA Resistance | about 20 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/05/2021
Avalon GloboCare Corp. is an intelligent biotech developer and healthcare service provider. The Company engages in the management of stem cell banks and specialty clinical laboratories. It is developing of exosome technology to improve the diagnosis and management of diseases. The Company operates through two platforms, Avalon Cell and Avalon Rehab. Its technology and service ecosystem covers the areas of regenerative medicine, cell-based immunotherapy, exosome technology, as well as rehabilitation medicine. The Company also focused on diagnostic advancements in the fields of oncology, infectious diseases and fibrotic diseases, and the discovery of disease-specific exosomes to provide the disease origin insight necessary to enable.
Sector: Healthcare
Industry: Medical Care
Keywords: Medicine Diseases Infectious Diseases Disease Immunotherapy Oncology Healthcare Service Regenerative Medicine Infectious Disease Fibrotic Disease Fibrotic Diseases Rehabilitation Medicine Exosome Vesicles Specialty
Classification
Sector: Healthcare
Industry: Medical Care
Keywords: Medicine Diseases Infectious Diseases Disease Immunotherapy Oncology Healthcare Service Regenerative Medicine Infectious Disease Fibrotic Disease Fibrotic Diseases Rehabilitation Medicine Exosome Vesicles Specialty
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.19 |
| 52 Week Low | 0.97 |
| Average Volume | 433,722 |
| 200-Day Moving Average | 1.31 |
| 50-Day Moving Average | 1.24 |
| 20-Day Moving Average | 1.11 |
| 10-Day Moving Average | 1.06 |
| Average True Range | 0.08 |
| ADX | 14.61 |
| +DI | 19.84 |
| -DI | 21.27 |
| Chandelier Exit (Long, 3 ATRs ) | 1.16 |
| Chandelier Exit (Short, 3 ATRs ) | 1.21 |
| Upper Bollinger Band | 1.27 |
| Lower Bollinger Band | 0.96 |
| Percent B (%b) | 0.2 |
| BandWidth | 27.84 |
| MACD Line | -0.06 |
| MACD Signal Line | -0.05 |
| MACD Histogram | -0.0049 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.17 | ||||
| Resistance 3 (R3) | 1.18 | 1.13 | 1.14 | ||
| Resistance 2 (R2) | 1.13 | 1.10 | 1.13 | 1.14 | |
| Resistance 1 (R1) | 1.08 | 1.07 | 1.10 | 1.07 | 1.13 |
| Pivot Point | 1.03 | 1.03 | 1.05 | 1.03 | 1.03 |
| Support 1 (S1) | 0.98 | 1.00 | 1.01 | 0.97 | 0.91 |
| Support 2 (S2) | 0.93 | 0.97 | 0.93 | 0.90 | |
| Support 3 (S3) | 0.88 | 0.93 | 0.90 | ||
| Support 4 (S4) | 0.87 |
